Disclaimer:
For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
 
Overview:
5-Amino 1MQ is a small-molecule compound studied for its potential effects on cellular metabolism, energy regulation, and body composition. It targets metabolic pathways involved in NAD⁺ biosynthesis and energy expenditure, making it a key subject of research in obesity and metabolic optimization studies.
Mechanism of Action:
5-Amino 1MQ acts as an inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme that regulates the methylation of nicotinamide. By inhibiting NNMT, it helps preserve intracellular NAD⁺ levels and enhance SIRT1 activity—pathways associated with improved mitochondrial function, increased energy metabolism, and reduced fat accumulation.
Research Highlights:
Demonstrated reduction in adipose tissue and enhanced fat metabolism in preclinical models.
Shown to increase cellular NAD⁺ availability and support mitochondrial efficiency.
Studied for its potential to improve energy balance, metabolic rate, and body composition.
Often researched alongside NAD⁺ precursors for synergistic metabolic effects.
Specifications:
Form: Capsules
Purity: ≥98% (HPLC-tested)
Storage: Keep sealed, in a cool, dry environment, protected from light.